Pluri expects 50% stake in ZEO ScientifiX under strategic agreement
PLUR•Pluri expects to hold a 50% stake in ZEO ScientifiX under a signed strategic agreement, subject to closing and transaction terms.
PLUR•Pluri expects to hold a 50% stake in ZEO ScientifiX under a signed strategic agreement, subject to closing and transaction terms.
Pluri expects to hold a 50% stake in ZEO ScientifiX under a signed strategic agreement, subject to closing and transaction terms. The deal targets expansion into the US regenerative medicine market through ZEO’s Florida biologics operations, marketed products and physician relationships.